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Abstract The recently described exchange protein directly
activated by cAMP (Epac) has been implicated in distinct
protein kinase A-independent cellular signalling pathways.
We investigated the role of Epac activation in adrenergi-
cally mediated ventricular arrhythmogenesis. In contrast to
observations in control conditions (n=20), monophasic
action potentials recorded in 2 of 10 intrinsically beating
and 5 of 20 extrinsically paced Langendorff-perfused wild-
type murine hearts perfused with the Epac activator 8-
pCPT-2′-O-Me-cAMP (8-CPT, 1 μM) showed spontaneous
triggered activity. Three of 20 such extrinsically paced
hearts showed spontaneous ventricular tachycardia (VT).
Programmed electrical stimulation provoked VT in 10 of 20
similarly treated hearts (P<0.001; n=20). However, there
were no statistically significant accompanying changes (P>
0.05) in left ventricular epicardial (40.7±1.2 versus 44.0±
1.7 ms; n=10) or endocardial action potential durations
(APD90; 51.8±2.3 versus 51.9±2.2 ms; n=10), transmural
(ΔAPD90) (11.1±2.6 versus 7.9±2.8 ms; n=10) or apico-
basal repolarisation gradients, ventricular effective refrac-
tory periods (29.1±1.7 versus 31.2±2.4 ms in control and
8-CPT-treated hearts, respectively; n=10) and APD90
restitution characteristics. Nevertheless, fluorescence imag-
ing of cytosolic Ca2+ levels demonstrated abnormal Ca2+
homeostasis in paced and resting isolated ventricular
myocytes. Epac activation using isoproterenol in the
presence of H-89 was also arrhythmogenic and similarly
altered cellular Ca2+ homeostasis. Epac-dependent effects
were reduced by Ca2+/calmodulin-dependent protein kinase
II (CaMKII) inhibition with 1 μM KN-93. These findings
associate VT in an intact cardiac preparation with altered
cellular Ca2+ homeostasis and Epac activation for the first
time, in the absence of altered repolarisation gradients
previously implicated in reentrant arrhythmias through a
mechanism dependent on CaMKII activity.
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Introduction
The second messenger cyclic adenosine monophosphate
(cAMP) is involved in the regulation of major physiological
processes in a wide range of cell types. For example,
regulation of cardiac ventricular physiology by cAMP has
long been viewed in terms of classical, protein kinase A
(PKA)-dependent pathways in which stimulation of β-
adrenoreceptors (BAR) activates the G protein Gs and
thence adenylate cyclase thereby elevating cytosolic
[cAMP]. The resulting PKA activation results in phosphor-
ylation of multiple targets involved in excitation–contraction
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coupling, including L-type Ca2+ channels (LTCCs), phos-
pholamban and the sarcoplasmic reticular (SR) cardiac
ryanodine receptor-Ca2+ release channel RyR2. The latter
releases the intracellularly stored Ca2+ in response to the
initial LTCC-mediated Ca2+ influx that leads to contractile
activation. This classical pathway is thought to lead to the
inotropic, chronotropic and lusitropic effects of cAMP
signalling [7].
An abnormally increased activation of this classical
pathway has been implicated in hypotheses for ventricular
arrhythmogenesis in both cardiac failure (HF) [58] and the
inherited arrhythmia disorder catecholaminergic poly-
morphic ventricular tachycardia (CPVT) [59], conditions
predisposing to sudden cardiac death (SCD) [31, 54]. Of
these conditions, HF has been described as involving
chronically elevated BAR-mediated cellular signalling
[57]. In contrast, CPVT, caused by mutations in the
calcium-handling proteins, calsequestrin (CasQ) or RyR2
[31], is associated with acute VT, which may degenerate
further into VF and SCD, on adrenergic stimulation [10].
The pathophysiology of both HF and CPVT has been
described in terms of schemes suggesting that PKA-
mediated phosphorylation of serine 2809 (or 2808, depend-
ing on species) of the RyR2 dissociates calstabin
(FKBP12.6) from the RyR2 increasing its open probability
(Po) [57]. However, (1) the exact phosphorylatable RyR2
sites [57, 62], (2) their individual protein kinases involved
whether they include PKA, calcium-calmodulin-dependent
protein kinase II (CaMKII) or protein kinase G (PKG) [8],
and (3) the functional roles of such phosphorylation, are
debated [8]. Finally, (4) some groups have not shown an
association between PKA-induced phosphorylation of the
RyR2 and a consequent FKBP12.6 dissociation [61].
Furthermore, discovery of the cAMP-dependent, ex-
change protein directly activated by cAMP (Epac) [16, 26]
has raised the possibility of alternative, PKA-independent,
cAMP-dependent mechanisms of action in catecholaminer-
gic BAR signalling. The Epac1 isoform is highly expressed
in the heart as part of the macromolecular signalling
complex regulating the RyR2, consisting of Epac, the
muscle-specific A-kinase anchoring protein (mAKAP),
PKA, and RyR2, and it has been suggested that there may
be a functional coupling between the RyR and Epac [18,
22]. Epac activation by agents such as the specific activator
8-4-(chlorophenylthio)-2′-O-methyladenosine-3′-5′-mono-
phosphate (8-CPT) both opens Ca2+-sensitive big K+
channels and increases Ca2+ mobilisation in cerebellar
neurones and stimulates Ca2+-induced Ca2+ release (CICR)
in pancreatic β-cells confirming a role for Epac in Ca2+
handling (reviewed by Bos [9]). 8-CPT at low concen-
trations has been shown to be highly specific in activating
Epac by up to 300-fold compared to activation of PKA
making it useful for investigating cAMP-dependent PKA-
independent processes [22, 25]. 8-CPT used in excess of
100 μM can activate PKA but with poor efficacy, activating
PKA at only 20–30% of full activity even at 1 mM 8-CPT
[11]. In this study, we accordingly use 1 μM 8-CPT to
activate Epac highly specifically. In cardiac cells, 8-CPT
increases the frequency of spontaneous cytosolic Ca2+
transients in neonatal rat cardiac myocytes [32]. Similarly,
8-CPT increases the amplitude of electrically evoked Ca2+
transients in murine cardiac myocytes [34]. Finally, 8-CPT
increases the frequency of Ca2+ sparks reflecting SR Ca2+
release in isolated rat ventricular myocytes [36].
In both HF and CPVT, it has been suggested that
alterations in RyR2 function could augment diastolic SR
Ca2+ release consequently increasing diastolic cytosolic
[Ca2+] potentially activating a transient inward current (Iti)
[6], driven by forward mode NCX sodium influx [21]. This
causes premature sarcolemmal depolarisation and triggered
activity that both causes systolic dysfunction and increases
arrhythmic tendency [38].
We directly investigated the effect of Epac activation by
8-CPT on arrhythmogenic tendency, confirmed with a
second method of Epac activation using isoproterenol plus
H-89, in an isolated perfused intact mouse heart model
paced at physiological heart rates for the first time. Our use
of the intact heart permits inclusion of factors that may
modulate abnormalities observed at the single cell level
when then considered at the whole organ level. Such factors
include intercellular electrical coupling and the arrangement
of myocytes, electrical conduction systems and spatial
heterogeneities of electrical properties reflected in nonun-
iformities of ion channel expression [48] and spatial
heterogeneities of repolarisation [51]. Use of a mouse
model permitted comparison with previous studies investi-
gating the role of PKA-dependent pathways [58, 59]. It also
permitted testing for and excluding reentrant mechanisms
previously demonstrated for LQTS-type genetically modi-
fied murine systems [52, 53]
Having established the effects of Epac activation in the
whole heart by two independent methods, 8-CPT and
isoproterenol plus H-89, we then proceeded to investigate
the effects of Epac activation at the cellular level and
related these to abnormalities in cytosolic Ca2+ handling.
We thus demonstrate, for the first time to our knowledge,
the arrhythmogenic consequences of Epac activation in any
whole heart preparation. In contrast to previous arrhythmo-
genic phenomena in murine models of LQTS [27, 45, 46,
51, 53], these phenomena were observed in the absence of
evidence for reentrant mechanisms within the left ventric-
ular free wall. Thus, alterations in transmural gradients of
repolarisation, apico-basal gradients of repolarisation and
action potential duration (APD) restitution were all absent.
Instead, such effects were associated with aberrations in
Ca2+ handling at the level of the single myocyte.
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Materials and methods
Experimental animals
Mice of the 129 background were kept in an animal house
facility at room temperature (21±1°C), subject to a 12:12 h
light/dark cycle. Sterile rodent chow and drinking water
were available at all times. Male and female mice aged 5–
7 months were used for the experiments.
Heart isolation
Mice were killed by rapid cervical dislocation in accor-
dance with Schedule 1 of the UK Animals (Scientific
Procedures) Act 1986. The isolated heart was quickly
excised and transferred to ice-cold bicarbonate-buffered
Krebs–Henseleit solution (mM: NaCl 119, NaHCO3 25,
KCl 4, KH2PO4 1.2, MgCl2 1, CaCl2 1.8, glucose 10 and
sodium pyruvate 2, pH 7.4) bubbled with 95% O2–5% CO2
[5]. A small section of aorta (3–4 mm) was identified and
cannulated with a tailor-made 21-gauge cannula that had
been prefilled with ice-cold buffer. The aorta was secured
onto the cannula with a micro-aneurysm clip (Harvard
Apparatus, UK). The heart was then rapidly transferred and
fixed to the perfusion system. The perfusate was passed
through 200 and 5 μm filters, and then warmed to 37°C by
a water jacket and circulator. Perfusion was commenced in
a retrograde manner through the aorta at 2–2.5 ml/min by a
peristaltic pump (Watson–Marlow Bredel pumps model
505S, Falmouth, Cornwall, UK). In this way, the heart was
perfused by the Krebs–Henseleit solution passing through
the aorta, into the coronary ostia, and then into the coronary
arteries, draining into the right atrium. After the initiation of
perfusion, hearts regained a pink colour and spontaneous
rhythmic contractions. After cannulation and the start of
perfusion, approximately 10% of hearts were discarded due
to ischaemia secondary to regional hypo-perfusion.
Perfused heart electrophysiology
Extrinsic stimulation was performed using paired platinum
electrodes (1 mm interpole distance) gently positioned at
the basal right ventricular epicardium. After initiation of
perfusion, hearts were paced at 8 Hz, using square wave
pulses 2 ms in duration, with a stimulation voltage set to
three times the diastolic threshold (Grass S48 Stimulator,
Grass-Telefactor, Slough, UK) allowing direct comparison
with previous murine studies of arrhythmogenesis [27].
Monophasic action potential (MAP) recordings were
made from the basal left ventricular epicardium using a
MAP electrode (Linton Instruments, Harvard Apparatus).
Endocardial MAPs were recorded with a custom-made
MAP electrode, composed from two strands of 0.25 mm
Teflon-coated silver wire (99.99% purity; Advent Research
Materials, UK). The tips of the endocardial MAP electrode
had previously been galvanically chlorided to eliminate DC
offset. The electrode was introduced through a small access
window made in the interventricular septum and then
positioned on the lateral aspect of the left ventricular
cavity, in opposition to the endocardial surface.
MAPs were pre-amplified using a NL100AK head stage,
amplified with a NL 104A amplifier and band pass filtered
between 0.5 Hz and 1 kHz using a NL125/6 filter
(Neurolog, Hertfordshire, UK) and then digitised (1401plus
MKII, Cambridge Electronic Design, Cambridge, UK) at
5 kHz. MAP waveforms were analysed using Spike2
software (Cambridge Electronic Design, UK).
Electrocardiograms (ECGs) were recorded from the
surface of the heart using commercially available ECG
electrodes (Harvard Apparatus, Kent, UK). ECGs were
recorded, amplified and filtered (0.1–100 Hz), with the
negative electrode posterior to the right atrium, and the
positive electrode at the ventricular apex.
Experimental protocol
After initiation of perfusion, hearts were paced at 8 Hz for
10 min. MAPs were then recorded at baseline. Programmed
electrical stimulation (PES) was used to assess inducibility
of ventricular arrhythmias [5]. The PES protocol used
consisted of a cycle of 8 S1 stimuli at a frequency of 8 Hz,
followed by a single extrastimulus, S2, initially 125 ms
after the eighth S1. The S1–S2 interval was progressively
reduced by 1 ms with each cycle. A ventricular arrhythmia
was defined as five or more consecutive premature
ventricular waveforms [27]. 8-CPT perfusion was then
begun, consisting of a 10 min delivery time to the heart,
during which hearts were paced at 8 Hz, followed by a
further 10 min of perfusion to allow the hearts to reach a
steady state before PES procedures and MAP acquisition
for quantification of MAP durations. A second independent
method of Epac activation employed isoproterenol in the
presence of the PKA inhibitor H-89. In such experiments,
hearts were initially perfused with 2 μM H-89 for 30 min,
followed by 100 nM isoproterenol in the continued
presence of H-89. In a separate study to investigate the
effects of BCL on left ventricular epicardial APD90, hearts
were paced with a dynamic pacing protocol [45]. This
began with a series of 100 stimuli at a BCL of 190 ms, with
the BCL reduced by 5 ms every 100 stimuli, until reaching
a BCL of 65 ms.
Isolation of ventricular cardiac myocytes
Solutions used for myocyte isolation were based on a stock
buffer (SB) consisting of (in mM): 125 NaCl, 4.75 KCl, 1.2
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MgSO4, 1.2 KH2PO4, 30 HEPES, 10 glucose, 50 taurine.
After isolation and cannulation, hearts were perfused
retrogradely with a perfusion buffer (PB) consisting of SB
with the addition of CaCl2 to a concentration of 0.75 mM
and adjusted to pH 7.4, for 1 min, followed by perfusion
with a nitrilotriacetic acid (NTA)-based perfusion buffer
consisting of SB, with NTA at 5 mM, adjusted to pH 6.95.
After 4 min, perfusion was switched to a digestion buffer
containing SB to which had been added 1.0 mg ml−1
collagenase type-2 (Worthington, UK) and 1 mg ml−1
hyaluronidase (Sigma-Aldrich, Poole, UK). After 10–
13 min digestion, the heart ventricular tissue was removed
carefully from the left ventricle using fine forceps.
Digestion was then terminated with PB containing 1 mg
ml−1 bovine serum album (Sigma-Aldrich, Poole, UK).
Cells were dissociated by gentle trituration and centrifuga-
tion. Ca2+ was gradually reintroduced to the cells, resulting
in a final concentration of 1.2 mM Ca2+. Cells were stored
at room temperature and used for experiments within 4–6 h.
Measurement of cytosolic Ca2+ transients
Cells were transferred onto laminin-coated coverslips
(Sigma-Aldrich, Poole, UK) and loaded with the acetox-
ymethyl (AM) ester of fluo-3 (Molecular Probes; Leiden,
The Netherlands) by incubation with 5 μM fluo-3 AM in
perfusion buffer for 30 min in the dark. Perfusion buffer
contained (in mM): 125 NaCl, 4.75 KCl, 1.2 MgSO4, 1.2
KH2PO4, 30 HEPES, 10 glucose, 50 taurine, 1.2 CaCl2.
Coverslips were then washed with perfusion buffer, and
transferred to a custom-made chamber. This chamber was
then mounted onto the stage of a Leica TCS SP5 confocal
scanning laser microscopy system. A ×63 water-immersion
objective lens (numerical aperture 1.2; confocal aperture
600 μm; slice thickness 20.5 μm) was used on a Leica 6000
CS inverted microscope. Fluo-3 was excited using a
488 nm argon laser, and emission was collected between
505 and 550 nm. Images were analysed using Leica AF
software and data exported to Microsoft Excel for analysis.
Fluorescence intensity (F) was measured in regions of
interest (ROIs) and normalised to the resting fluorescence
intensity (F0). A total of 250 to 500 frames were sampled at
a rate of 65 ms/frame, with each frame consisting of 256×
128 pixels. Recordings of fluorescence intensity were
verified in the line scan mode, with the scan line parallel
to the long axis of the cell and a recording rate of 1,400 Hz.
Data acquired in the line scan mode were analysed with
ImageJ (National Institutes of Health, Bethesda, MD,
USA). In experiments involving extrinsic stimulation, cells
were stimulated through two field electrodes, with pulses of
2 ms duration, at 0.5 Hz and 5 V above the excitation
threshold of 30–60 V. Perfusion solutions were changed as
required. The effects of Epac activation were measured 1 to
3 min after activation as reported previously [36]. In
experiments involving KN-93 or H-89, cells were inhibited
for 20 and 30 min, respectively, before recordings were
made. During subsequent pharmacological co-treatment,
recordings were made within 1 to 3 min. Experiments were
conducted at room temperature (22–24°C).
Pharmacological agents
8-pCPT-2′-O-Me-cAMP (BIOLOG Life Science Institute,
Bremen, Germany) was dissolved in doubly distilled water
to make a 1-mM stock solution and stored at −20°C. Final
drug concentrations were obtained by dilution with Krebs–
Henseleit buffer solution. 8-CPT was used at a final dose of
1 μM (see “Introduction” section), at which it is highly
specific for Epac over PKA [19], to minimise potential
nonspecific effects and to increase the physiological
relevance of consequent Epac activation. Furthermore, this
dose is equal to that used in previous reports demonstrating
increased phosphorylation of RyR2 [36] and alterations of
Ca2+ handling in rat cardiomyocytes [32]. Isoproterenol
(Sigma-Aldrich, Poole, UK) was dissolved in doubly
distilled water to make a 10-mM stock solution and stored
at −20°C and was used at a final concentration of 100 nM
[5]. KN-93 (Tocris Bioscience, Bristol, UK) was dissolved
in dimethyl sulfoxide to 10 mM stock and was used at a
final concentration of 1 mM [55]. H-89 (Sigma-Aldrich,
Poole, UK) was dissolved in doubly distilled water to give
a 2-mM stock and was used at a final concentration of
2 μM [30].
Statistical analysis
Results were expressed as means±SEM, and different exper-
imental groups were compared using analysis of variance
(SPSS software) and Student’s unpaired t test as appropriate,
with P values less than 0.05 considered significant. Categor-
ical data were compared with Fisher’s exact test (one-tailed),
with P values less than 0.05 considered significant.
Results
After isolation and cannulation, hearts were perfused with
Krebs–Henseleit solution. Extrinsic pacing was commenced
from the basal right epicardial surface, and 10 min was
allowed for the heart to reach steady-state. Programmed
electrical stimulation (PES) was performed to assess
arrhythmia inducibility in each pharmacological condition.
After allowing 10 min of perfusion in the test condition,
MAPs were recorded for 20 min under steady-state
conditions of regular pacing. Where used, KN-93 and H-
89 perfused the heart for 20 and 30 min, respectively,
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before experiments were commenced. During co-treatment
of hearts with H-89 and isoproterenol, or KN-93 with 8-
CPT, we then allowed a further 10-min perfusion before
PES was performed and MAPs were recorded. Closer
analysis of the time evolution of any observed arrhythmo-
genesis used electrocardiographic electrodes. The results of
these whole heart comparisons were, in turn, compared
with fluo-3 fluorescence intensity used to follow Ca2+
transients obtained in regularly stimulated and resting
ventricular myocytes before and after Epac activation.
Triggered activity occurs in both intrinsically beating
and regularly paced hearts in the presence of 8-CPT
We initially observed unstimulated, intrinsically beating,
hearts both under control conditions and after addition of 8-
CPT. In the absence of 8-CPT, such hearts never demon-
strated triggered activity (Fig. 1a; n=10) in agreement with
previous reports in isolated murine hearts under similarly
bradycardic, control conditions [20, 52]. In contrast, during
perfusion with 8-CPT, two out of ten such hearts developed
triggered activity (Fig. 1b; n=10).
The incidence of such triggered activity was then
systematically assessed in hearts regularly paced at a basic
cycle length (BCL) of 125 ms, close to physiological heart
rates in the mouse [35]. Control hearts demonstrated
consistently stable heart rates, with each monophasic action
potential (MAP) closely following the preceding extrinsic
stimulus, with no evidence of repolarisation abnormalities
over 20 min sampling periods (Fig. 2a).
In contrast, in the presence of 8-CPT, 5 out of 20 hearts
additionally demonstrated triggered activity occurring at
irregular times during or after the recovery phase of some
of the regularly occurring MAPs. This suggests a signifi-
cant arrhythmogenic effect (P<0.05, Fisher’s exact test; n=
20 and 20, control and 8-CPT-treated hearts, respectively).
Such triggered activity consisted of ectopic MAP wave-
forms occurring late in the recovery phase of the evoked
MAPs or even after their full repolarisation, in agreement
with the timing of either early afterdepolarisations (EADs)
[27] or delayed afterdepolarisations (DADs) [23] described
on previous occasions (Fig. 2b).
Spontaneous ventricular arrhythmia occurs in regularly
paced hearts in the presence of 8-CPT
Such triggered activity further led to the initiation of
episodes of spontaneous VT defined as five or more closely
coupled action potentials [27] in 3 out of 20 hearts. Such
episodes occurred in three out of the five hearts that showed
triggered activity. Spontaneous VT was never observed in
control hearts during steady pacing (n=20). Thus, in hearts
demonstrating triggered activity during 8-CPT treatment,
there was a significant tendency to spontaneous VT (P<
0.05, Fisher’s exact test; n=5 and 20, 8-CPT-treated and
control hearts, respectively).
Figure 3 shows the evolution of such a typical arrhythmia
after such ectopic activity in the presence of 8-CPT measured
by electrocardiographic (ECG) analysis. These findings are
in agreement with the corresponding evolution of human VF
in that they can involve a sequence of different waveforms
preceding the onset of VF [60]. Figure 3a demonstrates a
spontaneous ectopic beat that was closely interrupted by a
Fig. 1 Monophasic action potential (MAP) recordings from intrinsi-
cally beating hearts showed no triggered activity in control conditions
(a), whereas two out of ten hearts developed triggered activity (*)
during perfusion with 8-CPT (b). This was prevented by pretreatment
with KN-93 in seven out of seven hearts (c)
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succeeding pacing spike that led onto the development of a
sustained ventricular arrhythmia in an event resembling the
clinical R-on-T phenomenon [43]. Figure 3b illustrates the
subsequent monomorphic ECG waveform that then devel-
oped. However, this eventually evolved into a bidirectional
VT (Fig. 3c), in agreement with clinical reports describing
arrhythmogenesis in catecholaminergic polymorphic ventric-
ular tachycardia (CPVT) similarly associated with alterations
in Ca2+ homeostasis [31] and with an arrhythmogenic model
with an underlying abnormality of Ca2+ homeostasis and a
triggered as opposed to reentrant mechanisms of VT [10].
Finally, Fig. 3d demonstrates the final degeneration into
ventricular fibrillation (VF; within 80.6 s of initiation of the
arrhythmia). Such monomorphic VT, bidirectional VT and
ventricular fibrillation were never observed in control
conditions (n=20).
Programmed electrical stimulation induces ventricular
tachycardia in hearts following Epac activation
After the identification of these arrhythmogenic phenomena
in regularly paced hearts perfused with 8-CPT, programmed
electrical stimulation (PES) was used to systematically
assess arrhythmogenic tendency in response to provoked
extrasystolic stimulation at progressively closer intervals
Fig. 3 The range of ECG waveforms during steady-state pacing (S
indicates extrinsic pacing artefacts) after introduction of 8-CPT with
ventricular tachycardia (VT) developing spontaneously after a triggered
beat (*; a), changing successively into a self-sustaining monomorphic VT
(b) and bidirectional VT (c), and finally degenerating into ventricular
fibrillation (d). b–d are shown at twice the vertical magnification of (a)
Fig. 2 Monophasic action potential (MAP) recordings from extrin-
sically paced hearts in control conditions showing a typical regular
rhythm with each MAP directly after its preceding extrinsic stimulus
(a) then demonstrating triggered beats (*) during perfusion with 1 μM
8-CPT in 5 out of 20 hearts (b). This was prevented by KN-93
pretreatment in seven out of seven hearts (c)
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from the pacing stimuli, in isolated wild-type hearts
perfused in control conditions using Krebs–Henseleit
solution and then again during perfusion with 1 μM 8-
CPT. Such PES techniques were adapted from clinical
diagnostic techniques used to assess clinical arrhythmo-
genic tendency [27, 35, 47]. In control conditions, PES
consistently failed to induce VT in all of 20 hearts (Fig. 4a).
However, in the same 20 hearts then perfused with 1 μM 8-
CPT, 10 out of 20 hearts developed VT after provocation
using PES (Fig. 4b; n=20). These findings demonstrate a
significant arrhythmogenic effect of 8-CPT (P<0.001;
Fisher’s exact test).
We then confirmed the arrhythmogenic effects of Epac
by 8-CPT through a more physiological activation by an
increase in cytosolic [cAMP], increased by isoproterenol,
whilst inhibiting PKA with H-89. All hearts initially
perfused with the PKA inhibitor H-89 were refractory to
PES (n=8). However, in the same hearts then perfused with
isoproterenol in the continued presence of H-89, VT was
observed in five out of eight hearts, confirming a significant
arrhythmogenic tendency following Epac activation by this
second method of Epac activation (P<0.05 versus control).
Epac activation conserves action potential duration,
transmural gradient of repolarisation and ventricular
refractoriness
Previous work in both congenital and acquired LQTS has
attributed arrhythmogenic properties to reentrant mecha-
nisms attributable to alterations in epicardial and endocar-
dial APD90 given by the time from peak depolarisation to
90% repolarisation, the transmural gradient of repolarisa-
tion, ΔAPD90 given by the difference between endocardial
and epicardial APD90, the ventricular effective refractory
period (VERP) and the relationship between the VERP and
APD90. In such models, reentrant excitation was associated
with both repolarisation abnormalities serving as initiating
factors for arrhythmogenesis, coupled with abnormal
Fig. 4 Representative traces of
monophasic action potential
(MAP) recordings from isolated
Langendorff-perfused hearts
during programmed electrical
stimulation (PES) under control
conditions (a) in which PES
failed to induce ventricular
tachycardia (VT) in ten out of
ten hearts. During perfusion
with 8-CPT, PES led to VT that
was self-sustaining even after
cessation of pacing stimuli in 10
out of 20 WT hearts (P<0.001;
n=10) (b shows one of the five
hearts perfused with 8-CPT that
developed VT). CaMKII inhibi-
tion with KN-93 prevented 8-
CPT-induced VT in seven out of
seven hearts (c)
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gradients of repolarisation that contribute to a substrate for
reentrant circuits. However, the present findings suggested
a contrasting mechanism.
Firstly, arrhythmogenesis in murine models of human
LQT3 and LQT5, and of hypokalaemia has been attributed
to prolonged epicardial APD90 nevertheless associated with
either proportionately smaller or insignificant changes in
endocardial APD90 [20, 27, 51, 53]. The present experi-
ments were similarly performed using steady-state pacing at
8 Hz to determine epicardial and endocardial APD90. We
similarly observed that there was no significant change in
endocardial APD90 before and after application of 8-CPT
(51.8±2.2 ms versus 51.9±2.2 ms, respectively, (P>0.05;
n=10; Fig. 5)). We repeated APD90 measurements after
Epac activation by the second method, using isoproterenol
to stimulate cAMP production and H-89 to inhibit PKA.
Initial experiments confirmed that H-89 alone did not alter
APD90 in the epicardium (42.5±2.8 ms, n=7) nor in the
endocardium (50.0±2.7 ms, n=4).
However, our present results contrasted with the earlier
findings [20, 27, 51, 53] in that 8-CPT exerted no
significant effect on epicardial APD90. Thus, under control
conditions, the mean epicardial APD90 was 40.4±1.2 ms
(n=10; Fig. 5); however, after perfusion with 1 μM 8-CPT,
there was no significant change in mean epicardial APD90
at 44.0±1.7 ms (P>0.05; n=10). Epac activation by
isoproterenol in the presence of H-89 also did not alter
epicardial APD90 from control values (43.2±1.0, n=6).
Such hearts also showed a conserved endocardial APD90,
mean of 52.9±2.5 ms (n=6), not significantly different to
control (P>0.05).
Secondly, alterations in the consequent relationship
between the epicardial and endocardial APD90 have been
associated with arrhythmogenic substrates for reentrant
excitation in those earlier models of LQTS [27, 51, 53].
We therefore sought to determine whether alterations in
ΔAPD90 could be responsible for the arrhythmogenesis
observed due to Epac activation. The latent period between
stimulation and the peak of the evoked MAP did not
significantly differ between the epicardium and endocardi-
um, in control conditions and after Epac activation as
observed on previous occasions in the murine heart (data
not shown). The transmural gradient of repolarisation was
therefore calculated as the difference between the endocar-
dial and epicardial APD90, and represented by ΔAPD90 [27,
53]. In control conditions, we observedΔAPD90 to be 11.1±
2.6 ms (n=10), consistent with the positive values recorded
by previous investigators. We found no significant change
after perfusion with 8-CPT, with a ΔAPD90 equal to 7.9±
2.8 ms (n=10; Fig. 5). Using the second pharmacological
method, isoproterenol plus H-89, ΔAPD90 was 9.7±2.7 ms
(n=6), not different from the control (P>0.05). Hence, in
contrast to the previous models, an altered transmural
gradient of repolarisation is not associated with arrhythmo-
genesis due to Epac activation by either 8-CPT or isoproter-
enol plus H-89.
Thirdly, the VERP is the determinant of the time period
in which a myocardial region is capable of responding to a
stimulus, whether appropriate and originating from the
sinus node, or abnormal and due to ectopic or reentrant
electrical activity, and is therefore an important determinant
of local reexcitation. We assessed ventricular refractoriness
in intact hearts using a decremental pacing protocol in
control conditions versus Epac activation by either 8-CPT
or isoproterenol plus H-89. The VERP was given by the
shortest S1S2 interval that failed to elicit a MAP. After
perfusion with either 8-CPT (Fig. 5), or isoproterenol plus
H-89, there was no significant change in VERP (29.1±
1.7 ms, 31.2±2.4 ms and 31.3±3.0 ms; control, 8-CPT, and
isoproterenol plus H-89, respectively; n=10, n=10, and n=
6, respectively). Thus, relative changes in VERP alone are
not determinants of arrhythmogenic tendency due to Epac
activation.
Fourthly, it has additionally been suggested that the
relationship between the epicardial APD90 and epicardial
VERP is an important factor affecting arrhythmogenicity
based on findings in a hypokalaemic model of acquired
LQTS [44]. Thus, it has been proposed that there is a
critical window for reexcitation by a premature stimulus
given by the difference between the epicardial APD90 and
Fig. 5 Epicardial and endocar-
dial APD90, ΔAPD90 and VERP
in control conditions (clear bars;
n=10), during perfusion with
1 μM 8-CPT (black bars; n=10)
and in hearts pretreated with
1 μM KN-93 to inhibit CaMKII
and co-perfused with 8-CPT
(striped bars). All such parame-
ters were not significantly altered
from control values by 8-CPT or
KN-93 plus 8-CPT (P>0.05)
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the epicardial VERP. Hence, relative changes in VERP and
epicardial APD90, rather than the analysis of one such factor
in isolation may be required in a rigorous assessment of the
propensity to cardiac arrhythmogenesis. However, quantifi-
cation of the critical window in both control and 8-CPT-
treated hearts did not yield a significant difference (11.1±2.1
versus 12.8±3.0 ms, control and 8-CPT respectively; n=10
in both cases). A similar analysis for Epac activation by
isoproterenol plus 8-CPT also showed a conservation of this
critical window for reexcitation, 12.0±4.3 versus 11.1±
2.1 ms, isoproterenol plus H-89 and control respectively, P>
0.05, n=6 and 10). These findings are consistent with the
preservation of both the epicardial APD90 and VERP by
Epac activation, whilst also suggesting that neither changes
in refractoriness nor changes in the critical window are
determinants of arrhythmogenesis in this model.
Finally, in the absence of altered APD90, ΔAPD90 and
VERP, we investigated the apico-basal gradient of repolar-
isation. In hearts perfused with control solution, the apical
APD90 was 35.6±2.2 (n=10), significantly shorter than the
basal APD90 (40.2±1.3, n=10; P<0.05), consistent with
previous reports [3]. The resulting apico-base gradient of
repolarisation was −5.4±2.5 ms. Following Epac activation,
by either 8-CPT or isoproterenol and H-89, neither the
apical APD90 nor the apico-basal gradient of repolarisation
were significantly altered (Table 1).
Thus, these quantifications of the electrophysiological
effects of Epac activation by two independent pharmaco-
logical methods on intact Langendorff preparations, per-
formed for the first time, demonstrate both the initiation and
maintenance of spontaneous arrhythmogenic phenomena in
the face of normal epicardial and endocardial APD90,
ΔAPD90, VERP and apico-basal gradient of repolarisation
and therefore a preserved relationship between the APD90
and VERP. This sharply contrasted with changes observed
in previous murine models for reentrant arrhythmogenesis,
consistent with differing underlying arrhythmogenic mech-
anisms. These findings therefore argue for a mechanism of
arrhythmia distinct to one of reentrant excitation within the
left-ventricular free wall.
They also demonstrate the presence of repolarisation
abnormalities without the prolonged epicardial APD90,
further supporting previous results showing a lack of effect
of Epac activation on the APD at the cellular level [36].
Furthermore, some of these occurred after recovery of the
MAP to baseline. This is in contrast to the situation in
which prolonged APD90 may serve as an initiator of EADs
in models of LQTS by enhancing the ability for reactivation
of the L-type Ca2+ channel [24]. Such findings would be
compatible with recent suggestions of a scheme in which
VT in a mouse model of CPVT is initiated and maintained
by one or more ectopic foci [10].
The effect of stimulation rate on electrophysiological
properties during Epac activation
Finally, we proceeded to investigate the effect of BCL on
APD90 with a dynamic pacing protocol as used recently in
isolated perfused murine hearts [45, 46], whilst MAPs were
recorded from the left ventricular basal epicardium. Hearts
were paced for 100 stimuli at a BCL of 190 ms, with 5 ms
decrements in the BCL every 100 stimuli until reaching the
shortest BCL of 65ms. Firstly, we examined the effect of BCL
on the measured APD90 over this range of stimulation rates.
These results showed a general decrease in APD90 as BCL
was decreased. There was a minor prolongation of APD90s
over the entire range of BCLs during 8-CPT perfusion,
though there was no significant difference between control
and 8-CPT-treated hearts. This is shown in Fig. 6a.
Secondly, we assessed beat-to-beat variations in APD90
over the entire range of BCLs studied. The magnitude of
MAP alternans, a clinical predictor of arrhythmogenicity
[42], was given by the difference between odd and even
numbered MAPs [45]. We observed a general trend towards
increasing alternans magnitude as BCL decreased, in both
control and 8-CPT-treated hearts (Fig. 6b). Over the entire
range of BCLs, 8-CPT-treated hearts showed a slightly
larger alternans magnitude, especially at shorter BCLs, with
three out of five 8-CPT-treated hearts having an alternans
magnitude greater than 1 ms at BCLs of 70 and 65 ms,
compared to one out of five control hearts at a BCL of
70 ms, and two out of five control hearts at 65 ms. This
difference did not reach statistical significance (n=5 for
both control and 8-CPT-treated hearts).
Finally, the relationship of the APD90 to the diastolic
interval (DI) has been used to study action potential duration
restitution characteristics, and arrhythmogenic tendency has
been associated with increases in the maximum gradient of
Table 1 Basal and apical APD90 and the resultant apico-basal gradient of repolarisation recorded from isolated hearts extrinsically paced at 8 Hz
Condition Basal APD90 (ms) Apical APD90 (ms) Apex-base gradient (ms) P (versus control)
Control 40.2±1.3 (n=10) 35.6±2.2 (n=10) −5.4±2.5
8-CPT 44.0±1.7 (n=10) 36.7±3.2 (n=10) −7.4±3.7 NS
KN-93 + 8-CPT 43.8±2.8 (n=7) 36.8±4.3 (n=7) −7.1±3.9 NS
H-89 + isoproterenol 43.2±1.0 (n=6) 37.4±4.1 (n=6) −5.8±4.1 NS
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such curves. Such analyses have been extended to murine
hearts and correlated with arrhythmogenic tendency in
mouse models of human LQT3, Brugada syndrome and
hypokalaemia [45, 46]. A similar analysis in the present
study has been made by fitting the experimental data points
with a monoexponential function [45, 46] of the form:
y ¼ y0 þ A 1 ex=t
 
where y represents the APD90 and x represents the DI. A, ι
and y0 are constants obtained by fitting the function to the
experimental data points by a least squares method, using a
Levenberg–Marquardt algorithm. The values of these con-
stants and the reduced chi-squared values are given with the







Analysis of the maximum gradient observed at the lowest
experimental value of x revealed that control hearts showed a
Fig. 6 Control hearts (A) and 8-CPT-perfused hearts (B) were
investigated with a dynamic pacing protocol. APD90 decreased as
BCL decreased (a) though it did not significantly differ between
control and 8-CPT-treated hearts. Analysis of APD90 alternans (b)
showed an increase in alternans magnitude as BCL decreased in both
conditions. Restitution curves were obtained by plotting APD90
against the preceding DI (c) and data points were fitted with the
function y ¼ y0 þ A 1 ex=t
 
. The dashed line shows the gradient of
the fitted function. In neither conditions did the gradient exceed unity
over the range of experimental BCLs. Parameters used in curve fitting
in control conditions: y0=−9.9±2.2 ms, A=70.3±1.0 ms, t=70.5±
5.6 ms. Corresponding parameters for hearts perfused with 8-CPT:
y0=1.5±1.9 ms, A=56.9±0.8 ms, t=69.2±6.3 ms. Critical diastolic
interval (CDI) for control=−0.2 ms, CDI for 8-CPT perfused hearts=
-13.6 ms. Reduced χ2=0.027 and 0.025, control and 8-CPT,
respectively
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maximal gradient of 0.55±0.03 (n=5), and hearts treated
with 8-CPT showed a maximal gradient of 0.47±0.03 (n=5),
not significantly different to control (P>0.05; Fig. 6c). Thus,
restitution curves previously used to predict arrhythmoge-
nicity in a range of murine models failed to predict
arrhythmogenicity resulting from Epac activation. Previous
studies had extended the restitution analysis to predict the
critical DI (CDI), the DI at which the gradient would equal
unity, based on the fitted function [45, 46]. Testing this
concept here reveals a CDI less than zero in both control and
8-CPT-treated hearts, −0.16±0.02 ms versus −13.6±1.78 ms,
for control and 8-CPT-treated hearts, respectively (n=5 in
both cases). In both cases, restitution analysis would not
predict a gradient greater than one in any real as opposed to
negative BCL. If anything, the CDI was increased with 8-
CPT. Thus, action potential duration restitution properties
incorporating analysis of the maximum gradient observed and
predicted CDI fail to correlate with VT due to Epac
activation. This is in sharp contrast to murine studies of
arrhythmia consequent to LQTS and Brugada syndrome [46].
Epac-mediated arrhythmogenesis is dependent
on Ca2+/calmodulin-dependent protein kinase II
Previous reports have suggested that Ca2+/calmodulin-
dependent protein kinase II (CaMKII) activity is necessary
for Epac-mediated effects on Ca2+ handling in cardiac
myocytes [36]. We accordingly investigated the dependence
upon CaMKII of the arrhythmogenic features observed at
the whole organ level after Epac activation. KN-93 was
used to inhibit CaMKII at 1 μM after a careful review of
the literature. Thus KN-93 has been used at 1 μM to inhibit
CaMKII at the cellular [13, 36] and whole organ [55]
levels. Hearts were pretreated with KN-93 for 20 min
before experiments were performed [2]. For experiments
involving co-treatment with both 8-CPT and KN-93, 8-CPT
was perfused in the continued presence of KN-93, and a
further 10 min were allowed before PES was performed and
MAP recordings were made. Initial studies revealed that
KN-93 alone did not alter the epicardial APD90 (44.3±3.3,
n=7) nor endocardial APD90 (52.3±3.2 ms, n=4). Hearts
first perfused with KN-93 alone did not demonstrate
triggered activity or spontaneous VT. Perfusion with 8-
CPT in the continued presence of KN-93 then also failed to
show triggered activity and spontaneous VT (Fig. 1c).
Thus, KN-93 exerted an anti-arrhythmic effect in sponta-
neously beating hearts.
Hearts paced regularly at 8 Hz in the presence of KN-93
alone also showed no evidence of triggered activity or
spontaneous VT, similar to hearts perfused with control
solution. After perfusion with both KN-93 and 8-CPT in the
same seven hearts, there were no arrhythmogenic phenom-
ena of triggered activity or VT (Fig. 2c).
Stimulation of hearts by PES and treated with KN-93
alone failed to elicit VT in all hearts studied (n=7).
Perfusion of the same seven hearts with 8-CPT but in the
continued presence of KN-93 also failed to induce VT
(Fig. 4c), in sharp contrast to hearts perfused with 8-CPT
alone. Thus, KN-93 exerted a significant anti-arrhythmic
effect (P<0.05).
Such anti-arrhythmic actions of KN-93 occurred in the
absence of alterations in epicardial and endocardial APD90.
Thus, epicardial APD90 in the presence of KN-93 and 8-
CPT was 43.9±3.2 ms (n=7), and endocardial APD90 was
52.9±2.5 ms (n=7), not significantly different to controls
or 8-CPT-treated hearts. Thus, ΔAPD90 was 9.1±4.1 ms
(n=7) versus 11.1±2.6 ms (n=10) in controls, which did
not differ significantly. The VERP in hearts co-treated with
KN-93 and 8-CPT was 31.8±4.0 ms (n=7), and thus the
critical window was 12.1±5.2 ms (n=7). In addition, the
apico-basal gradient of repolarisation was not altered by
KN-93 compared to control, 8-CPT or isoproterenol plus H-
89 (P>0.05 in all such comparisons; Table 1). Therefore,
CaMKII inhibition rescued Epac-mediated VT without
alterations in epicardial or endocardial APD90, ΔAPD90,
apico-basal gradient of repolarisation, VERP or the critical
window.
Epac-mediated arrhythmogenesis correlates with altered
cytosolic Ca2+ transients in regularly paced ventricular
myocytes
Finally, having observed that Epac activation is arrhythmo-
genic at the level of the whole heart, yet with a
conservation of endocardial and epicardial APD90,
ΔAPD90 and refractory periods, we therefore sought to
determine whether abnormalities in Ca2+ handling at the
level of the single ventricular myocyte may be implicated
instead. Thus, abnormalities in cytosolic Ca2+ handling in
isolated myocytes have been associated with arrhythmo-
genesis at the level of the whole heart [4]. Furthermore,
Epac activation by 8-CPT has been associated with
abnormalities in Ca2+ handling in a wide number of cell
types, including rat ventricular myocytes [36].
Firstly, extrinsically paced myocytes perfused in control
solution demonstrated regular Ca2+ transients, in synchrony
with the pacing stimuli (n=27). Such cells showed
characteristic, regularly timed increases in F/F0 (Fig. 7a).
In sharp contrast, after perfusion with 8-CPT, 8 out of 16
paced cells demonstrated additional Ca2+ transients which
occurred at variable times out of synchrony with the
extrinsic pacing stimuli. Such differences in the observed
Ca2+ transients therefore reveal a significant effect of 8-
CPT on diastolic Ca2+ release (P<0.001, Fisher’s exact
test). Thus, the fluorescence signals demonstrated irregu-
larly timed rises in F/F0 in such cells (Fig. 7b,c). The mean
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peak F/F0 was not significantly altered by 8-CPT (3.07±
0.79 vs. 2.58±0.49, n=15 for 8-CPT treated cells, n=27 for
control cells). These results were confirmed in the line scan
mode in a further set of cells studied at the higher sampling
rate, where the mean maximum F/F0 was 3.13±0.23 in 8-
CPT-treated cells (n=16) and 2.94±0.23 in the absence of
8-CPT (n=22), without a statistically significant difference.
We then tested Epac activation by the second method of
activation. H-89 alone caused no ectopic Ca2+ transients
(n=14). Isoproterenol plus H-89, produced ectopic Ca2+
transients, in 4 out of 17 cells, statistically similar to the
effects of 8-CPT. These ectopic Ca2+ transients induced by
isoproterenol plus H-89 occurred in the absence of altered
mean peak F/F0 in both the frame scan mode (Table 2) and
confirmed with the line scan mode (Table 3). These results
are consistent with the hypothesis that such abnormal
cytosolic Ca2+ transients are arrhythmogenic predominantly
through abnormalities of diastolic as opposed to systolic
Ca2+ release.
Epac-mediated arrhythmogenesis correlates
with spontaneous cytosolic Ca2+ waves in resting
ventricular myocytes
Secondly, we proceeded to investigate Ca2+ transients in
resting as opposed to stimulated isolated ventricular
myocytes. In control conditions, such myocytes never
demonstrated any Ca2+ transients (n=20). In contrast, after
introduction of 8-CPT, there were significant alterations in
resting Ca2+ homeostasis as a consequence of the resulting
Epac activation. Thus, 9 out of 16 cells demonstrated
spontaneous Ca2+ transients (P<0.001, Fisher’s exact test;
n=20 and 16, control and 8-CPT-treated myocytes, respec-
tively), which took the form of Ca2+ waves in 9 out of 16
cells reflected in a fluorescent region that propagated either
uni- or bidirectionally along the long axis of the cell.
Activation of Epac by the second method using isoproter-
enol plus H-89 caused ectopic Ca2+ signals in 10 out of 18
cells, compared to none of 23 cells treated with H-89 alone,
a significant effect (P<0.001). These two methods of Epac
activation similarly caused ectopic Ca2+ transients in resting
cells.
Inspection of fluorescence intensity changes in spatially
successive frames acquired during the course of a typical
Fig. 7 Ca2+ signals observed in regularly stimulated ventricular
myocytes in control conditions showed a regular series of transients
directly after the extrinsic stimuli (a) in 22 out of 22 cells. In contrast,
Ca2+ signals observed during treatment with 8-CPT (b and c are
recordings from two different cells) showed ectopic Ca2+ transients
that were irregular, both in time and in peak magnitude, in 8 out of 16
cells (P<0.01). KN-93 significantly prevented the occurrence of 8-
CPT-induced ectopic Ca2+ transients in all cells (d; P<0.01 versus 8-
CPT, n=15). Triangles indicate extrinsic pacing stimuli
Table 2 Mean peak F/F0 signals recorded in paced myocytes in the
frame scan mode
Condition n F/F0 P (versus control)
Control 22 2.54±0.54
8-CPT 15 3.07±0.64 NS
KN-93 14 2.21±0.59 NS
8-CPT + KN-93 15 2.39±0.62 NS
Isoproterenol 16 3.57±0.89 <0.01
H-89 11 2.20±0.66 NS
Isoproterenol + H-89 15 2.85±0.69 NS
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Ca2+ wave induced by 8-CPT perfusion reveals this spatio-
temporal pattern of Ca2+ release (Fig. 8a). These phenom-
ena could be analysed by a comparison of F/F0 signals with
time through regions of interest (ROIs) placed at regular
intervals along the long axis of the cell being examined
(Fig. 8b). These ROIs yielded F/F0 traces with progressively
increasing latencies but otherwise similar increases in
intensity once such waves were established (Fig. 7c). Such
Ca2+ waves travelled at a constant velocity of 102.6±
14.1 μm s−1 (n=9), in close agreement to previously reported
velocities of resting Ca2+ waves in rat ventricular myocytes
Table 3 Mean peak F/F0 signals recorded in paced myocytes in the
line scan mode
Condition n F/F0 P (versus control)
Control 17 2.76±0.25
8-CPT 16 3.13±0.23 NS
KN-93 18 3.03±0.21 NS
8-CPT + KN-93 24 2.66±0.13 NS
Isoproterenol 10 3.74±0.18 <0.01
H-89 13 2.68±0.17 NS
Isoproterenol + H-89 18 3.07±0.23 NS
Fig. 8 Successive frame scan images demonstrate propagation of a
Ca2+ wave from one end of the cell to the other, moving along the axis
of the cell, from left to right in this view (a). The presence of 8-CPT
resulted in the spontaneous appearance of such travelling waves in
resting isolated myocytes in 9 out of 16 of myocytes. In contrast,
under control conditions, myocytes never showed such events (P<
0.001, Fisher’s exact test; n=16 and 20, 8-CPT-treated and control
myocytes, respectively). Frame dimensions 41.0×20.5 μm; 65 ms
between successive frames. Confocal transmitted light image of an
isolated ventricular myocyte (b), showing 6 ROIs, a to f. ROI
dimensions: 2 μm×2 μm. Fluorescence emission was analysed in
these successively spaced ROIs, revealing a delay in onset of the Ca2+
transient, the delay increasing with distance along the long axis of the
cell (c)
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[50]. Ca2+ waves are thought to exert arrhythmogenic effects
by producing Iti that itself underlies DADs, in turn leading to
triggered arrhythmias [6, 38, 50]. In such an event, the
observed Ca2+ waves in the presence of 8-CPT could be a
cellular manifestation of the proarrhythmic effects of 8-CPT.
Such cytosolic Ca2+ waves were also consistent with the
arrhythmogenic Ca2+ waves induced by caffeine in a
previous murine model of triggered ventricular arrhythmo-
genesis [4].
CaMKII inhibition prevents Epac-mediated abnormalities
of Ca2+ handling
Finally, in parallel with the antiarrhythmic effects CaMKII
inhibition at the level of whole hearts, CaMKII inhibition
also inhibited Epac-mediated changes in cellular Ca2+
handling in the following experiments.
Firstly, in paced cells, pretreatment with KN-93 was not
associated with ectopic Ca2+ transients (n=14) and there-
fore yielded results similar to control conditions (Fig. 7d).
However, cells treated with both 8-CPT and KN-93 also
failed to trigger ectopic Ca2+ transients (n=14). This
prevention of Epac-mediated ectopic Ca2+ transients by
KN-93 occurred without any change in peak F/F0 (Tables 2
and 3).
Secondly, in resting cells, pretreatment with KN-93 was
not associated with spontaneous Ca2+ transients in any cells
(n=15). Furthermore, KN-93 pretreatment significantly
reduced the incidence of spontaneous Ca2+ transients in
cells co-treated with KN-93 and 8-CPT, with ectopic Ca2+
signals seen in only 2 out of 16 cells. Thus, compared to
cells treated with 8-CPT alone, KN-93 significantly reduced
Epac-dependent spontaneous Ca2+ transients in resting
myocytes (P<0.01, Fisher’s exact test).
Discussion
Cardiac β-adrenergic signalling has been classically
explained in terms of a PKA-dependent signalling pathway
[7] activated by β-adrenoreceptor stimulation that involves
receptor binding of the ligand, Gs-protein and, consequent-
ly, adenylate cyclase activation, resulting in an elevation of
cytosolic cAMP and its activation of PKA. The increased
activity of PKA is suggested to phosphorylate RyR2
possibly at a key serine residue, thereby increasing RyR2
open probabilities and therefore diastolic Ca2+ leak in
cardiac myocytes leading to the arrhythmogenic effects
associated with catecholaminergic action in whole hearts
[57–59]. However, since the identification of Epac [16, 26],
cAMP-dependent, PKA-independent effects have also been
reported in different cell types, including pancreatic,
neuronal and cardiac cells [9].
We directly demonstrate, for the first time to our
knowledge that Epac activation results in ventricular
arrhythmogenesis in the whole mouse heart and relate these
to findings at the cellular level and complement recent
results from the rat at the cellular level [36].
As in previous studies of cAMP-dependent, PKA-
independent processes, we used two pharmacological
approaches to dissect out cAMP-dependent, PKA-independent
processes [9, 34]. The recent development of a membrane
permeant cAMP analogue, 8-pCPT-2′-O-Me-cAMP (8-CPT)
[19], provided selective Epac activation through a mecha-
nism independent of either PKA or LTCC modification at the
concentrations used here [19, 25, 36]. We used a lower dose
(1 μM) of 8-CPT than used previously [34, 36] to minimise
nonspecific and nonphysiological effects. Although the
affinity of cAMP for Epac1 in vitro has been reported in
the micromolar range [9, 40] in contrast to a nanomolar
affinity of cAMP binding to PKA [56], other reports, also in
vitro, show that the Kd for cAMP binding to PKA and Epac1
are similar, 2.8 μM for Epac1 [11] and 2.9 μM for PKA
[14]. Furthermore, recent studies employing Epac-based
FRET probes demonstrated micromolar fluctuations in
[cAMP] following agents known to stimulate its cellular
production, suggesting their capacity to activate Epac in vivo
[17, 28, 33, 39]. The effects of 8-CPT described in this study
were confirmed by activating Epac with a second pharma-
cological method. Thus, PKA was inhibited using H-89, in
combination with isoproterenol to stimulate production of
Epac’s physiological activator, cAMP, as also used previ-
ously [34].
We thus report for the first time that the Epac-activated
murine heart is capable of generating triggered activity and
spontaneously initiating and maintaining VT and showing
an increased tendency to provoked VT through the use of
PES, an electrophysiological test adapted from clinical
practice [27, 35, 47]. Such arrhythmogenesis resulted in the
development of multiple ECG waveforms that progressed
from a regular rhythm, through a monomorphic VT, to VF
that was in common with a similar sequence in the human
case [60]. In addition, such ECG analysis demonstrated that
Epac-activation also results in a sustained bidirectional VT.
The latter has been observed clinically in CPVT and in an
arrhythmogenic mouse model of CPVT associated with
underlying abnormalities of Ca2+ homeostasis with evi-
dence of a triggered as opposed to reentrant mechanism of
arrhythmia [10, 31].
These observed electrophysiological features differed
significantly from those associated with gene mutations in
ion channels associated with increases in epicardial APD90,
in turn leading to altered negative ΔAPD90s and increased
frequencies of EADs owing to consequent window currents
of LTCC reactivation [24]. These occur in murine models
of long QT syndromes (LQTS) 3 and 5 and hypokalaemic
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conditions and result in an arrhythmogenesis that has
been attributed to triggered and reentrant excitation in the
free wall of the left ventricle [27, 51, 53]. Subsequent
studies had further explored for and demonstrated criteria
for reentrant excitation [44] generated by increases in
APD90 relative to VERP values. In addition, temporal
factors such as the relationship between BCL and APD90,
APD alternans, and APD90 restitution [46] have been
proposed as predictors of arrhythmia in murine models of
LQTS.
However, the arrhythmogenic phenomena described here
took place in the absence of such electrophysiological
predictors. Thus, the Epac-mediated arrhythmias occurred
in the absence of prolonged epicardial APD90 whilst
endocardial APD90 values were preserved. This conse-
quently led to a normal ΔAPD90. Furthermore, there were
no alterations in VERP suggesting an unaltered relationship
between VERP and epicardial APD90. Temporal properties
reflected in APD90 restitution revealed no increase in the
maximum gradient of the restitution curve. In addition,
the apico-basal gradient of repolarisation was preserved in
the observed arrhythmogenesis.
Such arrhythmogenic features were instead associated
with significant abnormalities in Ca2+ handling at the
cellular level complementing previous reports correlating
arrhythmogenic tendency with alterations in Ca2+ handling.
These acute effects are additional to reported involvements
of Epac activation in cardiac hypertrophy [32] with
potential long-term effects on the development of arrhyth-
mogenic tendency [47] in rat neonatal cardiomyocytes.
Thus, experiments at the cellular level demonstrated a
significantly increased incidence of ectopic Ca2+ release in
both paced and resting cells after Epac activation. They
further showed a propensity to the generation of spontane-
ous Ca2+ waves, which had previously been associated with
triggered cardiac arrhythmogenesis through the generation
of Iti, which is thought to underlie DADs, in turn
underlying triggered mechanisms of VT [6, 38]. The
observed alterations in Ca2+ handling due to Epac activa-
tion by both methods occurred without significant alter-
ations in peak F/F0. This allowed an assessment of whether
ectopic Ca2+ release correlated with arrhythmogenic pro-
pensity. Previous reports using Epac activation with 10 μM
8-CPT gave conflicting alterations in peak F/F0 [34, 36].
Nevertheless, a previous study using 1 μM 8-CPT similarly
showed no change in the peak amplitude of spontaneous
Ca2+ oscillations in cultured rat cardiomyocytes [32]. These
results also complement recent reports confined to single
ventricular myocytes rather than whole hearts that had
demonstrated cAMP-dependent, PKA-independent altera-
tions in Ca2+ handling in cardiac myocytes. They also
demonstrated that Epac activation increases diastolic Ca2+
leak measured as Ca2+ sparks [36] and contributes to
isoproterenol-induced alterations in Ca2+ handling [34].
Another report has demonstrated β-adrenergic diastolic
Ca2+ leak that is independent of PKA whilst not directly
implicating Epac [13].
Together, these findings are consistent with a distinct
class of arrhythmogenic mechanisms associated with
normal APD90, ΔAPD90 and VERP, but abnormal cytosolic
Ca2+ homeostasis. They are compatible with speculative
schemes in which arrhythmia is initiated and maintained by
ectopic foci, as has been documented in human ventricular
arrhythmias [37] and in the mouse [10]. These may involve
micro-dispersions of refractoriness and repolarisation that
cannot be detected with the methods used in this study.
Alternatively, the increased ectopic Ca2+ release induced by
Epac activation may possibly serve as the initiator for
arrhythmias and their maintenance, through the increased
frequency of action potentials further maintaining the SR
Ca2+ load during any ensuing arrhythmia (see review by ter
Keurs and Boyden [50]). In addition, a rise in Ca2+ can
decrease the conduction velocity of an activation wavefront
[29]. A local rise in Ca2+ could in this way produce
functional block allowing the generation of a reentrant
circuit. Furthermore, computer simulations of spiral waves
show that nonuniformities of Ca2+ transients result in
destabilisation of the spiral waves [12] producing fibrilla-
tion. These possibilities whether involving the SR and
possibly also mitochondrial function [15] merit future
investigation.
Finally, our results demonstrate that both the arrhythmo-
genesis and the altered Ca2+ handling due to Epac
activation are significantly decreased by CaMKII inhibi-
tion. CaMKII has multiple targets [1] of which the LTCC
and Na+ channel could affect the action potential waveform
and refractory period, alterations in which are required to
establish the alternative LQTS-type reentrant arrhythmo-
genic mechanism [27, 44, 53]. However, Epac activation
does not appear to alter ICa nor APD [36]. A previous report
has shown increases in late Na+ current and rate-dependent
increases in APD90 relative to control in a mouse model of
CaMKII overexpression [55]. However, our results in acute
wild-type preparations do not show such changes in action
potential waveform whether with the initiation by Epac
activation by two independent methods, or in its rescue by
KN-93. Instead, we demonstrate changes in Ca2+ handling,
accordingly likely due to altered RyR2 properties demon-
strated previously by increased phosphorylation at the
CaMKII RyR2 site together with an increased spark
frequency [36] and consistent with the reported functional
coupling of Epac with the RyR2 [9, 18]. Our findings
accordingly further complement a previous report showing
that Ca2+ sparks in cardiac myocytes after Epac activation
are prevented by CaMKII inhibition [36]. This is compat-
ible with an Epac-mediated VT driven primarily by altered
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Ca2+ handling due to altered RyR2 properties with
consequent triggered arrhythmogenesis.
A role for Epac activation in physiological or at least
pathophysiological processes thus merits attention. These
features resemble arrhythmogenic phenomena known to
take place in the absence of reentrant substrate under other
circumstances that lead to alterations in Ca2+ homeostasis.
Thus arrhythmogenesis in the mouse heart is brought about
by addition of either caffeine or isoprenaline, both known
to alter Ca2+ homeostasis at the cellular level [4, 5].
The findings reported here also have implications for the
growing views that both cAMP signalling in general [16,
22, 26] and β-adrenergic stimulation leading to RyR2
activation as a specific example, are mediated by two
pathways. The latter have been broadly divided into both
PKA-dependent and PKA-independent mechanisms [13,
34, 36]. We suggest that the PKA-independent cAMP-
dependent pathways include an Epac-mediated mechanism
within the cAMP-dependent signalling pathway comple-
mentary to but not excluding PKA-mediated RyR2 activa-
tion in Ca2+-mediated arrhythmogenesis [57–59] in
conditions such as CPVT and triggered aspects of HF
[38]. Thus, future work focussing on the role of Epac may
contribute to an improved understanding of cardiac phys-
iology and explain current discrepancies in hypotheses
relying solely on the classical cAMP pathway.
These comparisons in murine systems also translate to
clinical observations. Thus, whilst changes in overall
repolarisation gradients may correlate with changes in QT
interval and have been implicated in arrhythmogenic
substrate in LQTS [41], patients with CPVT associated
with genetic defects in the RyR2 and CasQ [31] have a
normal QT interval [49], and so a normal gradient of
repolarisation as observed here is in keeping with the
clinical features and diagnostic criteria. Involvement of
Epac in ventricular tachycardia as demonstrated here also
suggests the need for further research into the possibility
that it may be a novel therapeutic target, particularly in HF
and CPVT. There are therefore potentially important
clinical implications of the research findings presented
here, warranting further investigation.
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